1 year return (CAGR)
3.85%
Crescent Biopharma, Inc. Exchange (NASDAQ, USD)
CBIO
13.50
+0.23 (+1.73%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
501.44M
Price/Sales
11.81
Ent value
349.35M
Price/Book
3.07
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
5.23%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 13.27 |
| Daily high | 13.59 |
| Daily low | 12.75 |
| Daily Volume | 239K |
| All-time high | 26.98 |
| 1y analyst estimate | 30.60 |
| Beta | - |
| EPS (TTM) | -5.41 |
| Dividend per share | 0.00 |
| Ex-div date | 13 Jan 2023 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CBIO | S&P500 | |
| Current price drop from All-time high | -49.96% | -0.87% |
| Highest price drop | -56.12% | -56.47% |
| Date of highest drop | 16 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -24.88% | -10.65% |
| Avg time to new high | 15 days | 12 days |
| Max time to new high | 132 days | 1805 days |
News
